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Background: Critical illness due to 2009 H1N1 influenza has been characterized by respiratory complications,
including acute lung injury (ALI) or acute respiratory distress syndrome (ARDS), and associated with high mortality.
We studied the severity, outcomes, and hospital charges of patients with ALI/ARDS secondary to pandemic
influenza A infection compared with ALI and ARDS from other etiologies.
Methods: A retrospective review was conducted that included patients admitted to the Cleveland Clinic MICU with
ALI/ARDS and confirmed influenza A infection, and all patients admitted with ALI/ARDS from any other etiology
from September 2009 to March 2010. An itemized list of individual hospital charges was obtained for each patient
from the hospital billing office and organized by billing code into a database. Continuous data that were normally
distributed are presented as the mean ± SD and were analyzed by the Student’s t test. The chi-square and Fisher
exact tests were used to evaluate differences in proportions between patient subgroups. Data that were not
normally distributed were compared with the Wilcoxon rank-sum test.
Results: Forty-five patients were studied: 23 in the H1N1 group and 22 in the noninfluenza group. Mean ± SD age
was similar (44 ± 13 and 51 ± 17 years, respectively, p= 0.15). H1N1 patients had lower APACHE III scores (66 ± 20 vs.
89 ± 32, p= 0.015) and had higher Pplat and PEEP on days 1, 3, and 14. Hospital and ICU length of stay and
duration of mechanical ventilation were comparable. SOFA scores over the first 2 weeks in the ICU indicate more
severe organ failure in the noninfluenza group (p= 0.017). Hospital mortality was significantly higher in the
noninfluenza group (77 vs. 39%, p= 0.016). The noninfluenza group tended to have higher overall charges,
including significantly higher cost of blood products in the ICU.
Conclusions: ALI/ARDS secondary to pandemic influenza infection is associated with more severe respiratory
compromise but has lower overall acuity and better survival rates than ALI/ARDS due to other causes. Higher
absolute charges in the noninfluenza group are likely due to underlying comorbid medical conditions.
Keywords: ARDS, ALI, Influenza A, Novel influenza, Mechanical ventilation, Hospital cost* Correspondence: Jwiesen1@gmail.com
1Resident, Internal Medicine, Cleveland Clinic Foundation, Cleveland, USA
6Respiratory Institute, A909500 Euclid Avenue, Cleveland, OH 44195, USA
Full list of author information is available at the end of the article
© 2012 Wiesen et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited.
Wiesen et al. Annals of Intensive Care 2012, 2:41 Page 2 of 8
http://www.annalsofintensivecare.com/content/2/1/41Background
The spread of a novel H1N1 strain of the Influenza A
virus represents the first pandemic of the 21st century
and the first influenza pandemic since 1968 [1]. Com-
pared with seasonal influenza, this strain was more
prevalent in younger-aged individuals, obese patients,
and pregnant women [2-12]. Severe cases of pandemic
H1N1 resulted in respiratory failure thought to be
secondary to direct cell damage and systemic cytokine
release resulting in acute lung injury (ALI) or acute
respiratory distress syndrome (ARDS) requiring pro-
longed ventilatory assistance and the frequent use of
rescue therapies [4,5,8,13-17].
Limited data exist that compare the clinical differences
between ALI in H1N1 patients and ALI arising from
other etiologies. Furthermore, whereas a number of
studies have assessed different aspects of the economic
impact of the recent pandemic [18-21], few have focused
on the health care cost of the pandemic, particularly the
utilization of limited ICU resources.
We report the severity, clinical outcomes, and hospital
charges of ALI/ARDS secondary to pandemic influenza
A infection compared with ALI/ARDS from other etiolo-
gies during a similar period of time. Based on clinical
bedside observations and published reports [4,5,8], we
hypothesize that ALI/ARDS secondary to pandemic in-
fluenza is associated with similar ICU outcomes but
increased resource utilization and higher hospital
charges due to the frequent need for rescue interven-
tions and prolonged ventilatory assistance.
Methods
The study was approved by the Human Investigation
Committee of the Cleveland Clinic Foundation (CCF)
(Institutional Review Board approval # 10–229) as a
retrospective, single-center study at the CCF Medical
ICU.
Patients were identified from a unit-based acute lung
injury screening database (Cleveland Clinic is one of the
centers participating in the ARDSnetwork) and the
H1N1 patient log maintained during the fall-winter sea-
son of 2009–2010. Patients were included if they met
criteria for ALI (PaO2/FiO2 ≤300; acute bilateral infil-
trates; positive pressure ventilation via endotracheal
tube; and no clinical evidence of left atrial hypertension
or congestive heart failure) between the months of Sep-
tember 2009 to March 2010—the time that influenza in-
fection was most prevalent. Diagnostic methods for
influenza A virus detection consisted of rapid antigen
testing, polymerase chain reaction (rtPCR), and viral cul-
ture from nasopharyngeal swabs, tracheal aspirates, and
bronchioalveolar lavage specimens. The patients were
grouped into two categories: those with laboratory-
proven H1N1 infection; and those in whom H1N1wasnot clinically suspected. Only patients with confirmed
infection were included in the influenza group to ensure
that the clinical course of the disease was accurately cap-
tured. Patients were excluded from the study if they did
not meet the above criteria for ARDS, or if clinical sus-
picion pointed to a likely pandemic viral infection with
negative diagnostics.
A Research Electronic Data Capture (REDCap) data-
base was constructed with a complete listing of the
patient’s demographic and clinical information, including
age, gender, height, weight, body mass index (BMI), pre-
senting symptoms, past medical history, primary reason
for admission to the ICU, vital signs, presence of vaso-
pressors, laboratory values, ventilator settings and re-
spiratory parameters, Acute Physiology and Chronic
Health Evaluation (APACHE) III and Sequential Organ
Failure Assessment (SOFA) scores on admission to the
MICU, number of intubated days, duration of ICU and
hospital stay, mortality, and rescue therapies (namely
inhaled nitric oxide, proning, high-frequency oscillatory
ventilation, and extracorporeal membrane oxygenation
[ECMO]) [22]. The data collection was de-identified and
collected in accordance with HIPAA guidelines.
As part of the routine MICU respiratory therapy proto-
col, mechanical ventilation parameters are recorded
every 4 hours. All patients are managed according to a
mechanical ventilation protocol that incorporates the use
of nonconventional modes when a lung protective strat-
egy on conventional modes failed to provide adequate
oxygenation. The following criteria were used to define
the analyzed parameters: 1) mode of ventilation: the
mode of ventilation that was used for the longest time
for a given day; 2) PaO2/FiO2: worst daily ratios were
recorded; 3) plateau pressure (Pplat): for patients on
volume control ventilation the airway pressure was mea-
sured after a 5-second inspiratory hold without concomi-
tant active inspiratory efforts, and for patients on
pressure control ventilation (PCV) the highest total sys-
tem pressure (PEEP + inspiratory pressure) was recorded;
4) positive end expiratory pressure (PEEP): the value cor-
responding to the highest PEEP for the day was recorded;
5) tidal volume (Vt): the largest daily volume was
recorded. Respiratory data were captured on the first day
of intubation (day 1) and then on subsequent days 3, 7,
and 14 of mechanical ventilation. There were no differ-
ences in ventilator protocols or management between
the two groups.
An itemized bill of individual charges for each patient
was obtained from the hospital billing office and was
organized by billing code into the following categories:
room/board, pharmacy, supplies, laboratory, radiology,
surgical (including procedures performed under general
anesthesia), blood products, respiratory services, dialysis,
and miscellaneous (which included some professional
Table 1 Demographics, comorbid medical conditions,
presenting symptoms, vital signs, laboratory values, and






Age (yr) 44 ± 13 51 ± 17 0.15
Gender (M:F) 10:13 11:11 0.77
BMI (kg/m2) 40 ± 22 32 ± 12 0.15
Comorbid medical conditions
Hypertension 13 12 0.57
Tobacco use 12 12 0.68
Chronic renal insufficiency 1 6 0.05
Malignancy 2 7 0.07
Immunosuppression 4 6 0.49
Alcohol abuse 1 6 0.05
Ischemic heart disease 1 4 0.19
Cirrhosis 0 4 0.05
Prior pulmonary disease 4 7 0.31
Presenting symptoms to ICU
Lower respiratory infection 100% (23) 73% (16) 0.135
CNS infection 0 4.5% (1) 0.489
Shock requiring vasopressors 22% (5) 45% (10) 0.07
Vital Signs
SBP (mm Hg) 131 ± 23 110± 19 0.004
DBP (mm Hg) 71.6 ±12 60.5 ± 10 0.004
Temperature (°C) 37.8 ± 1.5 37 ± 1.2 0.089
RR (breath/min) 23.4 ± 8.7 31.7 ± 21.4 0.14
HR (beats/min) 106 ± 27.3 108± 18 0.81
Laboratory values
WBC (k/μL) 10.6 ±7.46 11.4 ± 10.7 0.77
Platelets (k/μL) 196 ± 119 138± 127 0.12
Creatinine (mg/dL) 1.59 ± 1.13 1.62 ± 1.22 0.92
Bilirubin (mg/dL) 0.65 ± 0.46 3.3 ± 8.3 0.13
CK (U/L) 1155 ± 1642 723 ± 1551 0.45
Cause of ALI
Pneumonia 100% (23) 41% (9) <0.001
Sepsis 0 23% (5) 0.02
Aspiration 0 9% (2) 0.23
Transfusion reaction 0 5% (1) 0.49
Other 0 23% (5) 0.02
Acuity on ICU admission
APACHE III score 66 ± 20 (19) 89 ± 32 (20) 0.015
SOFA score 8.3 ± 3.4 9.2 ± 4.1 0.44
Length of stay (median± IQR)
ICU length of stay (days) 16 ± 22 24.5 ± 26.5 0.17c
Hospital length of stay (days) 12 ± 15 17 ± 25.5 0.45c
aValues expressed as mean ± SD unless otherwise noted; bt test or chi-squared;
cWilcoxon test. CNS, central nervous system; SBP, systolic blood pressure; DBP,
diastolic blood pressure; RR, respiratory rate; HR, heart rate; WBC, white blood
cell; CK, creatinine kinase; APACHE, Acute Physiology and Chronic Health
Evaluation; SOFA, Sequential Organ Failure Assessment.
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nostics not included in the other categories, such as
electroencephalograms, electrocardiograms, echocardio-
grams, cardiac catheterizations, and vascular studies).
The values represent the hospital charges for the afore-
mentioned services rather than the actual reimburse-
ment, which may be subject to more variability. The
single-center nature of the study removes interfacility
differences in clinical and billing practices.
Continuous data that were normally distributed are
presented as the mean ± SD and were analyzed by the
Student’s t test. The chi-square and Fisher exact tests
were used to evaluate differences in proportions between
patient groups. In instances where the data were not
normally distributed, the groups were compared with
the Wilcoxon rank-sum test. Differences were consid-
ered statistically significant if the p value was <0.05.
Results
Fifty-one patients were identified in the acute lung injury
screening database between September 2009 and March
2010. Twenty-two met criteria for ALI and did not have
confirmed or suspected H1N1 infection and were thus
included in the noninfluenza group (ALI/ARDS second-
ary to noninfluenza etiologies). Thirty-six patients in the
H1N1 patient log had confirmed influenza A testing. Of
those, 23 had ALI requiring mechanical ventilation
(MV) during their MICU stay and were included in our
analysis.
Demographics, presenting symptoms, past medical
history, and acuity on admission are shown in Table 1.
Patients in the influenza group tended to be younger
with a higher BMI. Patients in the influenza group pre-
sented more often with lower respiratory infection (100
vs. 73%, p= 0.135) and had increased requirement for
mechanical ventilation on admission to the ICU (96 vs.
68%, p= 0.022). On the other hand, the noninfluenza
group had a higher propensity to present with shock re-
quiring vasopressors (45 vs. 22%, respectively, p= 0.07).
The primary cause of ALI in the H1N1 group was pneu-
monia (n = 23), whereas in the noninfluenza group the
etiologies were more varied, including pneumonia
(n = 9), sepsis (n = 5), aspiration of gastric contents
(n = 2), transfusion reaction (n = 1), and other (n = 5).
Whereas seven patients (30%) in the H1N1 group were
considered healthy, only one patient (5%) in the nonin-
fluenza group had no comorbid medical conditions on
admission to the ICU (Table 1). This difference is
reflected in the lower mean APACHE III score on ad-
mission to the ICU in the H1N1 group (66 ± 20 vs.
89 ± 32, p= 0.015), despite similar SOFA scores (8.3 ± 3.4
and 9.2 ± 4.1, p= 0.44).
There were no statistically significant differences be-
tween the two groups for initial laboratory data,







Day 1 8.8 ± 3.8 12.4 ± 3.8 0.003
(23) (22)
Day 3 8.7 ± 4.3 11.2 ± 4.6 0.07
(23) (21)
Day 7 9.0 ± 4.3 12.4 ± 4.3 0.01
(21) (17)
Day 14 7.6 ± 6.4 9.3 ± 6.1 0.37
(11) (14)
aAll values expressed as mean ± SD. Using mixed models, the overall p value
comparing the influenza and noninfluenza groups is 0.017. The trend over
time was not significant (p= 0.1).
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atinine, bilirubin, and creatinine kinase. The number of
patients who developed acute renal failure that required
dialysis throughout their ICU stay was the same (n = 8)
in both groups. SOFA scores on days 1, 3, 7, and 14 of
mechanical ventilation indicate that patients in the non-
influenza group had more severe organ failure during
their ICU stay (p= 0.017; Table 2).
Table 3 shows oxygenation index and mechanical ven-
tilation related parameters on days 1, 3, 7, and 14. There
was a nonsignificant trend toward worsening hypoxia in
the H1N1 group, despite significantly higher PEEP and
Pplat on days 1, 3, and 14. Tidal volumes were compar-
able throughout. Plateau pressures in the H1N1 group
were high due to the relative decrease in pulmonary
compliance in H1N1-related lung injury. Four patients
in both groups were ventilated with airway pressure re-
lease ventilation (APRV). More patients in the influenza
group required rescue therapies on day 1 of mechanical
ventilation (4 vs. 0, respectively, p= 0.108); however,
similar numbers of patients in both groups required res-
cue therapies over the duration of MV (7 and 5 patients,
respectively). Rescue therapies in the H1N1 group
included inhaled NO (n = 4), ECMO (n = 2), prone venti-
lation (n = 3), and high-frequency ventilation (n = 1), andTable 3 Oxygenation indices and mechanical ventilation para
Day 1 of mechanical
ventilation
Day 3 of mechanic
ventilation
Influenza







PaO2/FiO2 150± 107 156± 95 181± 82 206 ± 8
PPlat (cm H2O) 37 ± 8 25± 6
a 34 ± 7 24± 7
PEEP (cm H2O) 16 ± 6 9.3 ± 6
a 15 ± 7 9.2 ± 6
Vt (mL/kg) 7.7 ± 1.4 7.4 ± 1.1 8.5 ± 2 7.6 ± 1
ap< 0.05 with t test.in the noninfluenza group only inhaled NO (n = 3) and
prone ventilation (n = 2).
Mechanical ventilation days were comparable between
groups (22 ± 17 vs. 19 ± 15 days for groups I and II, re-
spectively, p= 0.53) as were 28-day ventilator-free days
(5 ± 7.6 and 4.6 ± 9, p= 0.88). Four patients in the H1N1
group and seven in the noninfluenza group underwent a
tracheostomy procedure. Hospital and ICU LOS were
comparable (median ± IQR: 16 ± 22 vs. 24.5 ± 26.5 and
12 ± 15 vs. 17 ± 25.5 days for the influenza group and II,
respectively, Wilcoxon p= 0.17 and 0.45). Mortality was
significantly higher for patients in the noninfluenza
group (77 vs. 39%, p= 0.016). Interestingly, a Kaplan-
Meier curve of ICU mortality (Figure 1) indicates that
patients in the H1N1 group were more likely to be dis-
charged alive from the ICU when the length of stay was
greater than 25 days, despite a trend toward higher mor-
tality within the first 2 weeks.
Even though all charges were higher in the nonin-
fluenza group, only the difference in blood products
utilized in the ICU was significant (4 ± 6 vs. 21 ± 25
thousands of U.S. dollars, Wilcoxon p < 0.001; Table 4).
Differences in ICU charges in pharmacy (p= 0.23),
supplies (p= 0.09), radiology (p= 0.08), and miscellan-
eous (p= 0.09) were large but not significant due to
considerable variation. The proportion of charges in
each of the major categories was similar between the
groups (Figure 2). The average total ICU cost per pa-
tient (253 ± 193 vs. 350 ± 270 thousands of U.S. dollars,
Wilcoxon p= 0.19) and the average ICU cost per pa-
tient per day (13 ± 4 vs. 15 ± 6 thousands of U.S. dol-
lars, Wilcoxon p= 0.06) tended to be higher in the
noninfluenza group.Discussion
The fall of 2009 heralded the influx of patients suffering
from severe hypoxic respiratory complications secondary
to the pandemic H1N1 influenza to ICUs across the
country. Due to the severity of pulmonary disease that
many of these patients experienced, perception among
treating clinicians was that these patients would havemeters on days 1, 3, 7, and 14
al Day 7 of mechanical
ventilation












0.2 185 ± 96 230 ± 118 148 ± 69 251 ± 146
a 31 ± 10 25 ± 9 38 ± 9 24± 4a
a 13 ± 6.4 9.5 ± 6.4 14 ± 7.4 8 ± 4.3a
8 ± 2 8 ± 2.6 7.7 ± 1.8 8 ± 1.8
Figure 1 Kaplan-Meier curve of ICU mortality (log rank, p=0.26).
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sured by hospital charges, than patients who developed
ALI from other etiologies. We demonstrated that, con-
trary to what was perceived, pandemic influenza A ALI/
ARDS was associated with a lower acuity and, conse-
quently, lower hospital mortality that ALI/ARDS from
other etiologies, and had a similar ICU and hospital
LOS. ICU and total hospital charges reflected a trend to-
ward higher overall charges for room and board, blood
products, pharmacy, and overall charge per patient in
the noninfluenza group.
In accordance with other descriptive reports of pan-
demic influenza [2-12], patients who tested positive for
H1N1 infection, tended to be young (no patientsTable 4 Mean hospital charges per patient (in thousands of U
ICU charges
Influenza
(n = 23 )
Non influenza
(n = 22 )
Influ
(n =
Room/board 71 ± 53 81 ± 62 15
Pharmacy 29 ± 35 54 ± 74 12
Supplies 4 ± 4 6 ± 7 1
Laboratory 63 ± 50 74 ± 55 27
Radiology 10 ± 9 17± 15 2
Surgical 3 ± 5 5 ± 10 6
Blood products 4 ± 6 21 ± 25c 4
Respiratory Services 31 ± 22 36 ± 28 7
Dialysis 4 ± 8 4 ± 6 2


















aMiscellaneous includes professional fees, nonsurgical procedures and phlebotomy,
electroencephalograms, electrocardiograms, echocardiograms, cardiac catheterizatio>64 years old), obese (15 had BMI >30 kg/m2), and in
relatively good health (30% with no comorbid medical
conditions). There were no pregnant patients in either
group. Compared with other studies of pandemic influ-
enza patients who required mechanical ventilation,
SOFA scores (mean 8.3) were similar, although APACHE
II (25 ± 9) scores were higher [5-8,14,16,17,23]. The de-
gree of respiratory compromise in our patients was more
severe than other reports judging by the higher PEEP
requirements and longer duration of mechanical ventila-
tion, which was roughly double that reported in other
studies [4-6,8,11,13,14,16,23]. Plateau pressures in these
studies were not consistently reported. However, despite
significantly longer ventilation duration and prolonged.S. dollars)




(n = 13 )
Influenza
(n = 23 )
Non influenza
(n= 22 )
± 30 13 ± 17 86 ± 65 94 ± 69
± 31 16 ± 34 41 ± 49 70 ± 92
± 3 1 ± 2 5 ± 6.5 8 ± 7
± 82 12 ± 10 90 ± 99 86 ± 58
± 4 5 ± 5 12 ± 10 22 ± 17
± 15 1 ± 3 9 ± 18 7 ± 11
± 11 5 ± 12 8 ± 15 27 ± 34c
± 11 5 ± 5 37 ± 25 40 ± 29
± 7 .1 ± 0.35 6 ± 13 4 ± 6

















and diagnostics not included in the other categories, such as














































































Figure 2 Percentage of ICU charges by category. **Miscellaneous includes professional fees, nonsurgical procedures and phlebotomy, and
diagnostics not included in the other categories, such as electroencephalograms, electrocardiograms, echocardiograms, cardiac catheterizations,
and vascular studies.
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not higher than that seen in other studies, which ranged
from 22–41% in patients who required mechanical venti-
lation [4-6,8,11,13,14,16,23].
Looking at the different patient characteristics between
groups, it may be tempting to postulate that the higher
rate of patients with pulmonary ARDS in the H1N1
group, in contrast to prevalent nonpulmonary ARDS in
the noninfluenza group, would correlate with a higher
PEEP response among the latter [24]. Our findings sug-
gest the contrary. Patients in the H1N1 group had
higher mean plateau pressure, likely indicative of lower
compliance. The similarity of PaO2/FiO2 ratios in the
two groups may be a reflection of higher PEEP values
used in the H1N1 group for lung recruitment, rather
than being indicative of comparable degrees of lung in-
jury. Although assessing recruitability from this retro-
spective analysis is difficult and may be inaccurate, the
higher PEEP used and the implication of lower compli-
ance observed are predictors of potentially recruitable
lung [24]. These observations support the recent call for
a reevaluation of the ALI and ARDS criteria to account
for this heterogeneity in the patient population [25].
A number of important differences between the two
cohorts emerged as well. As expected, the noninfluenza
group was older, had more comorbid medical condi-
tions, and less often presented to the ICU with respira-
tory failure. The degree of ventilator support was
significantly higher in the H1N1 group on days 1, 3, and
14, and there was a trend to more severe hypoxemiaduring that time as well. Nevertheless, the use of use of
APRV and rescue therapies was comparable in both
groups. Despite more severe respiratory compromise,
H1N1 patients did not have longer time on the ventila-
tor, longer ICU or hospital stays, or higher mortality. Al-
though SOFA scores were similar, the noninfluenza
group had significantly higher APACHE III scores, likely
secondary to points assigned to comorbid medical con-
ditions. The high acuity of illness, as well as the presence
of severe comorbidities, such as solid and hematologic
oncologic conditions (7 patients), chronic renal insuffi-
ciency (6 patients), and cirrhosis of the liver (4 patients),
likely contributed to the poor outcomes in the nonin-
fluenza group. Conversely, despite more severe respira-
tory compromise, patients in the H1N1 group were
more likely to recover due to their younger age and bet-
ter overall health histories.
The 77% mortality in the noninfluenza group was
much higher than typically reported in clinical trials,
with one notable exception [26]. However, reports from
tertiary care centers involving patient cohorts with simi-
lar underlying comorbid conditions have reported
equally high mortality rates [27]. Our observation brings
up an interesting point, namely the difference between
the reported mortality in clinical trials and the observed
mortality in a similar clinical condition affecting patients
that would have been excluded from such trials due to
coexisting comorbidities. A Kaplan-Meier plot of ICU
mortality (Figure 1) indicates that although patients in
the H1N1 group were less likely to survive the first
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were more likely to be discharged alive from the hos-
pital. Patients in the noninfluenza group were unlikely
to survive if their ICU length of stay exceeded 3 weeks.
ARDS is among the most expensive conditions
encountered in the ICU [28]. In 1984, Bellamy and Oye
described the charges of patients with ARDS, with the
most expensive being room and board (30%), clinical la-
boratory (24%), pharmacy (14%), and inhalation therapy
and ventilation (8%) [27]. Twenty-five years later, our
study indicates that the aforementioned categories con-
tinue to represent the most expensive charges incurred
by ARDS patients in the ICU.
The overall similarity of charges in room and board
and respiratory therapy between the two groups is likely
indicative of the comparative durations of hospitalization
and mechanical ventilation. Interestingly, despite higher
ventilatory requirements and more severe hypoxemia in
the H1N1 group, respiratory charges were similar be-
tween the two groups, suggesting that the high cost of
maintaining a patient on mechanical ventilation is inde-
pendent of the degree of ventilator support necessary.
Thus, respiratory charges are more likely a reflection of
duration of mechanical ventilation rather than the de-
gree of ventilator support necessary. Absolute ICU
charges for room and board, blood products, pharmacy,
radiology, average daily charge, and overall charge per
patient were larger in the noninfluenza group. ICU
charges for blood products in the noninfluenza group
were greater by a factor of four, and pharmacy charges
double that of the H1N1 group. This finding is likely a
reflection of the higher prevalence of underlying comor-
bid medical conditions in the noninfluenza group, such
as malignancy and cirrhosis, which require expensive
medications and predispose to anemia. Moreover, the
high mortality in this cohort likely precluded even
higher hospital charges. Nevertheless, the H1N1 cohort
amassed charges of similar magnitude to the most ill
and expensive patients in the ICU, indicating the abun-
dant health care resources consumed by severe pan-
demic influenza infection.
There are a number of limitations to our study. As a
retrospective chart review rather than a prospective in-
vestigation, the information was culled from sources that
were at times incomplete. Second, the study contained a
relatively small number of patients, and measures taken
to ensure internal validity of each group, such as limiting
the influenza group to confirmed H1N1 infection and
the noninfluenza group to the duration of the influenza
season, further limited its size. Additionally, whereas our
study provides descriptive information relevant to the
patient population of our institution and tertiary referral
centers with similar acuity, other ICUs may be exposed
to a different cohort of patients. On the other hand, as asingle-center study, potential differences in clinical and
billing practices could be minimized. Although a com-
prehensive charge profile of each patient was generated,
trends in the timing of charges could not be obtained.
Finally, the hospital charge data were mined from an ex-
tensive database divided by charge coding, and therefore,
some charges may have been mislabeled or inappropri-
ately categorized.Conclusions
Our study provides interesting observations about the
clinical course, outcomes, and cost of the H1N1 influenza
pandemic. Although patients with severe pulmonary com-
plications of pandemic influenza infection have poor oxy-
genation and require significant ventilatory support and
rescue therapies, their younger age and tendency to have
fewer comorbid medical conditions contribute to their
improved prognosis compared with patients with ALI
from other causes. Both groups of patients consume enor-
mous amounts of hospital resources, and physicians and
policy makers must be aware of this when future pan-
demics arise.
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